loading
Collegium Pharmaceutical Inc stock is traded at $45.63, with a volume of 107.81K. It is down -1.57% in the last 24 hours and down -4.08% over the past month. Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.
See More
Previous Close:
$46.30
Open:
$46.33
24h Volume:
107.81K
Relative Volume:
0.23
Market Cap:
$1.44B
Revenue:
$566.77M
Net Income/Loss:
$48.16M
P/E Ratio:
38.34
EPS:
1.19
Net Cash Flow:
$274.29M
1W Performance:
-8.56%
1M Performance:
-4.08%
6M Performance:
+49.37%
1Y Performance:
+59.18%
1-Day Range:
Value
$45.48
$46.46
1-Week Range:
Value
$45.48
$50.79
52-Week Range:
Value
$23.23
$50.79

Collegium Pharmaceutical Inc Stock (COLL) Company Profile

Name
Name
Collegium Pharmaceutical Inc
Name
Phone
781-713-3699
Name
Address
100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA
Name
Employee
357
Name
Twitter
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
COLL's Discussions on Twitter

Compare COLL with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
COLL
Collegium Pharmaceutical Inc
45.63 1.46B 566.77M 48.16M 274.29M 1.19
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
125.47 55.45B 9.40B 2.65B 2.24B 5.935
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.62 49.25B 29.63B 260.53M 5.51B 0.0788
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.02 45.02B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
30.66 35.81B 16.88B 666.71M 251.19M 0.6132
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
491.72 20.98B 3.08B 1.24B 1.07B 25.61

Collegium Pharmaceutical Inc Stock (COLL) Upgrades & Downgrades

Date Action Analyst Rating Change
Dec-09-25 Initiated Barclays Overweight
Jan-10-25 Upgrade Needham Hold → Buy
Jul-30-24 Upgrade H.C. Wainwright Neutral → Buy
Jun-07-24 Upgrade Jefferies Hold → Buy
May-10-24 Downgrade Needham Buy → Hold
May-10-24 Downgrade Piper Sandler Overweight → Neutral
Jan-04-24 Downgrade Jefferies Buy → Hold
Aug-25-23 Reiterated Needham Buy
May-02-23 Resumed Jefferies Buy
Aug-08-22 Downgrade H.C. Wainwright Buy → Neutral
Feb-15-22 Upgrade Cantor Fitzgerald Neutral → Overweight
Aug-06-21 Downgrade Cantor Fitzgerald Overweight → Neutral
Jan-11-21 Reiterated H.C. Wainwright Buy
Jul-14-20 Initiated BWS Financial Sell
May-27-20 Initiated Guggenheim Neutral
Feb-19-20 Resumed Jefferies Buy
Oct-30-19 Reiterated Needham Buy
May-03-19 Resumed H.C. Wainwright Buy
Apr-12-19 Resumed Janney Buy
Mar-20-19 Initiated SunTrust Hold
Jan-16-19 Reiterated Needham Buy
Mar-08-18 Reiterated H.C. Wainwright Buy
Feb-07-18 Reiterated Needham Buy
Dec-05-17 Reiterated Needham Buy
Sep-11-17 Initiated H.C. Wainwright Buy
May-11-17 Reiterated Needham Buy
Sep-13-16 Initiated Gabelli & Co Buy
Jun-01-15 Initiated Jefferies Buy
Jun-01-15 Initiated Needham Buy
Jun-01-15 Initiated Piper Jaffray Overweight
View All

Collegium Pharmaceutical Inc Stock (COLL) Latest News

pulisher
Dec 30, 2025

Collegium Pharmaceutical (NASDAQ:COLL) Stock Price Down 5%Here's What Happened - MarketBeat

Dec 30, 2025
pulisher
Dec 30, 2025

Collegium Announces the Closing of $980 Million Syndicated Credit Facility - The Globe and Mail

Dec 30, 2025
pulisher
Dec 30, 2025

Liquidity Mapping Around (COLL) Price Events - Stock Traders Daily

Dec 30, 2025
pulisher
Dec 30, 2025

Collegium Pharmaceutical Closes New $980 Million Credit Facility - TipRanks

Dec 30, 2025
pulisher
Dec 30, 2025

Collegium Pharmaceutical Closes $980 Million Syndicated Credit Facility - marketscreener.com

Dec 30, 2025
pulisher
Dec 30, 2025

Collegium Pharmaceutical Signs Credit Agreement With Truist Bank - TradingView — Track All Markets

Dec 30, 2025
pulisher
Dec 30, 2025

Collegium Pharmaceutical, Inc. Announces the Closing of $980 Million Syndicated Credit Facility - marketscreener.com

Dec 30, 2025
pulisher
Dec 29, 2025

Pacer Advisors Inc. Sells 87,066 Shares of Collegium Pharmaceutical, Inc. $COLL - MarketBeat

Dec 29, 2025
pulisher
Dec 28, 2025

2 Reasons to Avoid COLL and 1 Stock to Buy Instead - Yahoo Finance

Dec 28, 2025
pulisher
Dec 26, 2025

Collegium Pharmaceutical stock hits all-time high at 49.92 USD By Investing.com - Investing.com Nigeria

Dec 26, 2025
pulisher
Dec 26, 2025

Collegium Pharmaceutical (NASDAQ:COLL) Hits New 12-Month HighStill a Buy? - MarketBeat

Dec 26, 2025
pulisher
Dec 26, 2025

Collegium Pharmaceutical stock hits all-time high at 49.92 USD - Investing.com India

Dec 26, 2025
pulisher
Dec 24, 2025

Is Collegium Pharmaceutical Inc a good long term investmentMarket Rumors and News & High Yield Trading Plans - earlytimes.in

Dec 24, 2025
pulisher
Dec 22, 2025

Should Value Investors Buy Collegium Pharmaceutical (COLL) Stock? - sharewise.com

Dec 22, 2025
pulisher
Dec 22, 2025

Are Medical Stocks Lagging Actinium Pharmaceuticals (ATNM) This Year? - Yahoo Finance

Dec 22, 2025
pulisher
Dec 22, 2025

Assenagon Asset Management S.A. Purchases 92,898 Shares of Collegium Pharmaceutical, Inc. $COLL - MarketBeat

Dec 22, 2025
pulisher
Dec 21, 2025

Can Collegium Pharmaceutical Inc. stock sustain free cash flow growthTrade Entry Summary & Daily Profit Maximizing Trade Tips - bolumsonucanavari.com

Dec 21, 2025
pulisher
Dec 21, 2025

Will Collegium Pharmaceutical Inc. stock benefit from commodity pricesInsider Buying & Advanced Technical Analysis Signals - Улправда

Dec 21, 2025
pulisher
Dec 20, 2025

How rising interest rates impact Collegium Pharmaceutical Inc. stockWeekly Investment Report & Safe Capital Investment Plans - Улправда

Dec 20, 2025
pulisher
Dec 20, 2025

Is Strong Q3 Beat And Higher Guidance Altering The Investment Case For Collegium Pharmaceutical (COLL)? - Yahoo Finance

Dec 20, 2025
pulisher
Dec 20, 2025

Can Collegium Pharmaceutical Inc. stock beat market expectations this quarterQuarterly Portfolio Summary & Free Weekly Chart Analysis and Trade Guides - Улправда

Dec 20, 2025
pulisher
Dec 19, 2025

Understanding the Setup: (COLL) and Scalable Risk - Stock Traders Daily

Dec 19, 2025
pulisher
Dec 19, 2025

Published on: 2025-12-19 17:44:17 - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

Is Collegium Pharmaceutical Inc. stock positioned for digital transformationJuly 2025 Weekly Recap & Risk Controlled Swing Alerts - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

3 Unpopular Stocks We Find Risky - Finviz

Dec 19, 2025
pulisher
Dec 19, 2025

Will Collegium Pharmaceutical Inc. stock deliver strong dividend growthMarket Volume Report & Comprehensive Market Scan Reports - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

Will Collegium Pharmaceutical Inc. stock benefit from infrastructure spendingJuly 2025 Sentiment & High Conviction Investment Ideas - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

How Collegium Pharmaceutical Inc. stock performs in weak economy - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

Trade Recap: Will Collegium Pharmaceutical Inc. stock benefit from infrastructure spending2025 Support & Resistance & Reliable Intraday Trade Plans - DonanımHaber

Dec 19, 2025
pulisher
Dec 18, 2025

Collegium Pharmaceutical Earnings Notes - Trefis

Dec 18, 2025
pulisher
Dec 18, 2025

Can Collegium Pharmaceutical Inc. stock outperform in 2025 bull marketJuly 2025 Movers & Long Hold Capital Preservation Tips - Улправда

Dec 18, 2025
pulisher
Dec 18, 2025

Best Value Stocks to Buy for Dec. 18 - sharewise.com

Dec 18, 2025
pulisher
Dec 17, 2025

Strong Q3 Beat and Guidance Upside Might Change The Case For Investing In Collegium Pharmaceutical (COLL) - simplywall.st

Dec 17, 2025
pulisher
Dec 17, 2025

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives Average Rating of "Buy" from Brokerages - MarketBeat

Dec 17, 2025
pulisher
Dec 16, 2025

Is Collegium Pharmaceutical (NASDAQ:COLL) A Risky Investment? - 富途牛牛

Dec 16, 2025
pulisher
Dec 16, 2025

Collegium Pharmaceutical (COLL): Valuation Check After Strong Revenue Beat and Upgraded Full-Year Performance - simplywall.st

Dec 16, 2025
pulisher
Dec 16, 2025

Collegium Pharma spikes after 2025 outlook - MSN

Dec 16, 2025
pulisher
Dec 15, 2025

Collegium Pharmaceutical (NASDAQ:COLL) Sets New 1-Year HighShould You Buy? - MarketBeat

Dec 15, 2025
pulisher
Dec 14, 2025

Branded Pharmaceuticals Stocks Q3 Recap: Benchmarking Collegium Pharmaceutical (NASDAQ:COLL) - Yahoo Finance

Dec 14, 2025
pulisher
Dec 14, 2025

Needham Upgrades Collegium Pharmaceutical (COLL) - MSN

Dec 14, 2025
pulisher
Dec 11, 2025

Collegium Pharmaceutical Inc 354 Stock Analysis and ForecastMarket Volatility Update & Exceptional Return Growth - earlytimes.in

Dec 11, 2025
pulisher
Dec 11, 2025

Insider Selling: Collegium Pharmaceutical (NASDAQ:COLL) EVP Sells 17,600 Shares of Stock - MarketBeat

Dec 11, 2025
pulisher
Dec 11, 2025

Collegium Pharmaceutical stock hits all-time high at 49.11 USD By Investing.com - Investing.com Canada

Dec 11, 2025
pulisher
Dec 11, 2025

Collegium Pharmaceutical stock hits all-time high at 49.11 USD - Investing.com

Dec 11, 2025
pulisher
Dec 11, 2025

1 Growth Stock Set to Flourishand 2 Facing Challenges - The Globe and Mail

Dec 11, 2025
pulisher
Dec 10, 2025

Collegium pharmaceutical EVP Dreyer sells $847k in stock - Investing.com India

Dec 10, 2025
pulisher
Dec 10, 2025

Collegium pharmaceutical EVP Dreyer sells $847k in stock By Investing.com - Investing.com Australia

Dec 10, 2025

Collegium Pharmaceutical Inc Stock (COLL) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Collegium Pharmaceutical Inc Stock (COLL) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Dreyer Scott
EVP & Chief Commercial Officer
Dec 08 '25
Option Exercise
15.90
17,600
279,840
121,213
Dreyer Scott
EVP & Chief Commercial Officer
Dec 08 '25
Sale
48.17
17,600
847,855
103,613
Balice-Gordon Rita J.
Director
Dec 05 '25
Sale
47.03
3,650
171,673
52,629
drug_manufacturers_specialty_generic RGC
$21.20
price up icon 1.43%
$22.14
price down icon 2.14%
drug_manufacturers_specialty_generic RDY
$13.88
price down icon 1.18%
$140.52
price down icon 0.54%
$12.36
price down icon 0.28%
$490.50
price up icon 0.67%
Cap:     |  Volume (24h):